Skip to main content

Animations

MJFF Publications

391 - 400 of 6078 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • OPEN
    Title: Loss-of-function variants in ITSN1 confer high risk of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00752-9
    Citation Count: 2
  • OPEN
    Title: The angiotensin (1–7) glycopeptide PNA5 improvescognition in achronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926
    Citation Count: 2
  • OPEN
    Title: Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29960
    Citation Count: 3
  • OPEN
    Title: Exposure to household pesticides and Parkinson's disease in the Parkinson's Progression Markers Initiative cohort
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1411468
    Citation Count: 2
  • OPEN
    Title: A worldwide study of white matter microstructural alterations in people living with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00758-3
    Citation Count: 6
  • OPEN
    Title: LRRK2 kinase activity is necessary for development and regeneration in Nematostella vectensis
    Journal Name: Neural Development
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s13064-024-00193-3
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Multiple sclerosis in LRRK2 G2019S Parkinson’s disease and isolated nigral degeneration in a homozygous variant carrier
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1450654
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: Naturally occurring hyperactive variants of human parkin
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s42003-024-06656-x
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Acoustically targeted measurement of transgene expression in the brain
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adj7686
    Citation Count: 1
  • OPEN
    Title: Contrastive machine learning reveals Parkinson’s disease specific features associated with disease severity and progression
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s42003-024-06648-x
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.